Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of d-Ala 1 -peptide T-amide for HIV-1-associated cognitive-motor impairment

Author： Goodkin Karl   Vitiello Benedetto   Lyman William   Asthana Deshratn   Atkinson J   Heseltine Peter   Molina Rebeca   Zheng Wenli   Khamis Imad   Wilkie Frances   Shapshak Paul  

Publisher： Ashgate Publishing Ltd

ISSN： 1355-0284

Source： Journal of NeuroVirology, Vol.12, Iss.3, 2006-07, pp. : 178-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized, Double-Blind, Placebo-Controlled International Clinical Trial of the AMPAKINE® CX516 in Elderly Participants with Mild Cognitive Impairment

By Johnson S.A.   Simmon V.F.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 197-200

Humana Press, Inc

Access to resources Recommend Favorite

Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment

By Schifitto Giovanni   Zhong Jianhui   Gill David   Peterson Derick   Gaugh Michelle   Zhu Tong   Tivarus Madalina   Cruttenden Kim   Maggirwar Sanjay   Gendelman Howard   Dewhurst Stephen   Gelbard Harris  

Journal of NeuroVirology, Vol. 15, Iss. 2, 2009-04 ,pp. : 176-186

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS

By Beghi Ettore   Pupillo Elisabetta   Bonito Virginio   Buzzi Paolo   Caponnetto Claudia   Chiò Adriano   Corbo Massimo   Giannini Fabio   Inghilleri Maurizio   Bella Vincenzo La   Logroscino Giancarlo   Lorusso Lorenzo   Lunetta Christian   Mazzini Letizia   Messina Paolo   Mora Gabriele   Perini Michele   Quadrelli Maria Lidia   Silani Vincenzo   Simone Isabella L.   Tremolizzo Lucio  

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 14, Iss. 5-6, 2013-09 ,pp. : 397-405

Informa Healthcare

Access to resources Recommend Favorite

A Randomized, Double-Blind, Placebo-Controlled Trial of Two Doses of Ginkgo Biloba Extract in Dementia of the Alzheimer's Type

By  

Current Alzheimer Research, Vol. 2, Iss. 5, 2005-12 ,pp. : 541-551

Bentham Science Publishers

Access to resources Recommend Favorite

Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy–treated subjects with human immunodeficiency virus type 1 infection

By Sun Bing   Abadjian Linda   Rempel Hans   Calosing Cyrus   Rothlind Johannes   Pulliam Lynn  

Journal of NeuroVirology, Vol. 16, Iss. 2, 2010-04 ,pp. : 115-124

Ashgate Publishing Ltd

Access to resources Recommend Favorite